Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

The branding was unveiled in advance of an analyst ... arguing that the remaining stake created an overhang for 'new GSK', which will focus on prescription medicines and vaccines.

Then his mother, Alia Hayes, got some bad news. The manufacturer, GSK, was going to stop manufacturing the brand-name ...

The biggest vaccine brand it has acquired in the deal is Bexsero, a new vaccine to prevent meningitis B, with a further candidate vaccine in late-stage development, MenABCWY. GSK intends to report ...

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

Latin America Cargo City is a single brand of Corporación ... Lacalle Pou “welcomed GSK's announcement of the opening of one of its three new regional vaccine distribution centers in Uruguay”.

GSK shares jumped as much as 6.5% on Thursday after the British drugmaker struck a $2.2 billion settlement over U.S. lawsuits that alleged its discontinued heartburn drug Zantac caused cancer.

New Delhi: GlaxoSmithKline's antibiotic drug Augmentin ... GSK's Augmentin has continued to maintain its top selling brand position. "Augmentin continues to be GSKs hallmark of quality and trust ...

GSK, which developed and sold versions of the ... a now-discontinued blockbuster heartburn drug commonly known by the brand name Zantac. GSK, which developed the drug decades ago and sold a ...

GSK has faced a long-running saga around Zantac, which is the brand name for the drug ranitidine. The product reduces the amount of acid the stomach makes, and was a best-seller in the UK and US ...

The new campus - which will sit next to GSK's existing site at Stevenage ... company's consumer healthcare division, which makes big-brand products including Sensodyne and Panadol.

When it does, it will probably prefer to issue more shares of stock, assuming it can't get one of its collaborators, like GSK, to fund further efforts. People who buy the stock today are thus ...